Best of ASCO - 2014 Annual Meeting

 

Welcome

Attend this session at the
2019 ASCO Annual Meeting!


Session: Health Services Research, Clinical Informatics, and Quality of Care

Type: Poster Session

Time: Saturday June 1, 1:15 PM to 4:15 PM

Location: Hall A

Quality of life (QOL) in patients undergoing CAR-T therapy versus stem cell transplant (SCT).

Sub-category:
Outcomes

Category:
Health Services Research, Clinical Informatics, and Quality of Care

Meeting:
2019 ASCO Annual Meeting

Abstract No:
6594

Poster Board Number:
Poster Session (Board #285)

Citation:
J Clin Oncol 37, 2019 (suppl; abstr 6594)

Author(s): Surbhi Sidana, Amylou C. Dueck, Michelle Burtis, Joan M. Griffin, Gita Thanarajasingam, Rahma M. Warsame, Carrie A. Thompson, Andrea L. Cheville, Morie A. Gertz, Kathleen J. Yost, Angela Dispenzieri, Jose Villasboas Bisneto, Jonas Paludo, Stephen M. Ansell, S. Vincent Rajkumar, Nabila Nora Bennani, Patrick B. Johnston, Mustaqeem Ahmad Siddiqui, Yi Lin, Shaji Kumar; Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AZ; Mayo Clinic, Health Sciences Research, Rochester, MN; Division of Hematology, Mayo Clinic, Rochester, MN

Abstract Disclosures

Abstract:

Background: Given the significant short-term adverse effects of CAR-T cell therapy, it is important to evaluate its impact on QOL of patients in addition to efficacy, compared with established forms of cellular therapy like SCT. Methods: QOL was evaluated prospectively in patients undergoing CAR-T therapy, autoSCT & alloSCT for hematologic malignancies. QOL was assessed with FACT-G at baseline, 2 weeks and monthly for 6 months thereafter. Functional well-being (FWB), physical WB (PWB) emotional WB (EWB) & social WB (SWB) and change over time were compared across groups. Results: 45 patients were recruited (CAR-T: 10; Auto SCT: 22; Allo SCT: 13) with follow up for 2 weeks & 1 month available for 23 &15 patients, respectively (Table). There was no statistically significant difference in baseline total QOL scores (p=0.13), though scores were lower in the alloSCT group (85,84,68). EWB &FWB were numerically higher in the CAR-T group, followed by autoSCT group. At 2 weeks, overall QOL decreased by only 2 points in CAR-T group vs. 22 & 18 points in auto & alloSCT groups (p=0.09). Change in PWB vs. baseline was less pronounced in the CAR-T group (-1, -9, -13, p=0.03). At 1 month, overall QOL was 6 points lower than baseline in CAR-T group vs. 3 and 14 points lower in auto & alloSCT groups, respectively (p=0.34). Importantly, PWB had at least returned to baseline in the CAR-T group. Conclusions: Preliminary data show that patients undergoing CAR-T cell therapy do not experience a more significant decline in QOL compared with auto & allo SCT, and may experience fewer physical side effects in the short-term. Accrual & follow-up are ongoing.

CAR-T
N=10
Auto SCT
N=22
Allo SCT
N=13
P-value
Median age, years62.562.261.40.9
FACT-G Baseline Median
Physical WB (0-28)1922200.70
Social WB (0-28)2424.5220.12
Emotional WB (0-24)2019160.12
Functional WB (0-28)20.518140.09
Total FACTG (0-108)8584680.13
QOL Change Week 2 vs. BaselineN=7N=10N=6
Physical WB-1-9-130.03
Social WB00.500.72
Emotional WB1110.88
Functional WB-2-8-60.40
Total FACTG-2-22-180.09
QOL Change Month-1 vs. BaselineN=5N=5N=5
Physical WB1-2-40.73
Social WB-10-20.41
Emotional WB2210.93
Functional WB-9-1-80.21
Total FACTG-6-3-140.34

 
Other Abstracts in this Sub-Category:

 

1. Longitudinal toxicity analysis with novel summary metrics of lenalidomide maintenance in follicular lymphoma in ECOG-ACRIN 2408.

Meeting: 2019 ASCO Annual Meeting Abstract No: 6511 First Author: Gita Thanarajasingam
Category: Health Services Research, Clinical Informatics, and Quality of Care - Outcomes

 

2. Comparative effectiveness of proton therapy versus photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer.

Meeting: 2019 ASCO Annual Meeting Abstract No: 6521 First Author: Brian Christopher Baumann
Category: Health Services Research, Clinical Informatics, and Quality of Care - Outcomes

 

3. Clinical outcomes and cost-effectiveness of breast cancer screening for childhood cancer survivors treated with chest radiation: A comparative modeling study.

Meeting: 2019 ASCO Annual Meeting Abstract No: 6525 First Author: Jennifer Yeh
Category: Health Services Research, Clinical Informatics, and Quality of Care - Outcomes

 

More...